JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Checklist", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Databases, Factual", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Economic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality-Adjusted Life Years", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 52 Avenue Andr\u00e9 Morizet, 92100, Boulogne-Billancourt, France", 
          "id": "http://www.grid.ac/institutes/grid.455095.8", 
          "name": [
            "Department of Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 52 Avenue Andr\u00e9 Morizet, 92100, Boulogne-Billancourt, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bou\u00e9e-Benhamiche", 
        "givenName": "Elsa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 52 Avenue Andr\u00e9 Morizet, 92100, Boulogne-Billancourt, France", 
          "id": "http://www.grid.ac/institutes/grid.455095.8", 
          "name": [
            "Department of Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 52 Avenue Andr\u00e9 Morizet, 92100, Boulogne-Billancourt, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bousquet", 
        "givenName": "Philippe Jean", 
        "id": "sg:person.016320413375.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016320413375.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Economic and Public Health Evaluation, French National Authority for Health (Haute Autorit\u00e9 de Sant\u00e9, HAS), 5 Avenue du Stade de France, 93218, Saint-Denis La Plaine CEDEX, France", 
          "id": "http://www.grid.ac/institutes/grid.457361.2", 
          "name": [
            "Department of Economic and Public Health Evaluation, French National Authority for Health (Haute Autorit\u00e9 de Sant\u00e9, HAS), 5 Avenue du Stade de France, 93218, Saint-Denis La Plaine CEDEX, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghabri", 
        "givenName": "Salah", 
        "id": "sg:person.01276215131.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276215131.43"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/11314110-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021346102", 
          "https://doi.org/10.2165/11314110-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12913-018-3080-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103149138", 
          "https://doi.org/10.1186/s12913-018-3080-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2191-1991-3-21", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015691190", 
          "https://doi.org/10.1186/2191-1991-3-21"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-013-0109-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020308192", 
          "https://doi.org/10.1007/s40273-013-0109-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-018-0711-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106679621", 
          "https://doi.org/10.1007/s40273-018-0711-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-016-2482-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043250857", 
          "https://doi.org/10.1186/s12885-016-2482-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40258-018-0393-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104261461", 
          "https://doi.org/10.1007/s40258-018-0393-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10198-018-1024-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111160623", 
          "https://doi.org/10.1007/s10198-018-1024-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-14-586", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005873826", 
          "https://doi.org/10.1186/1471-2407-14-586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1177/2168479014532259", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064086698", 
          "https://doi.org/10.1177/2168479014532259"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2020-02-14", 
    "datePublishedReg": "2020-02-14", 
    "description": "BackgroundOncology is among the most active therapeutic fields in terms of new drug development projects, with increasingly expensive drugs. The expected clinical benefit and cost effectiveness of these treatments in clinical practice have yet to be fully confirmed. Health medico-administrative databases may be useful for assessing the value of anticancer drugs with real-world data.ObjectiveThe objectives of our systematic literature review (SLR) were to analyse economic evaluations of anticancer drugs based on health medico-administrative databases, to assess the quality of these evaluations, and to identify the inputs from such databases that can be used in economic evaluations of anticancer drugs.MethodsWe performed an SLR by using PubMed and Web of Science articles published from January 2008 to January 2019. The search strategy focused on anticancer drug cost-effectiveness analyses (CEAs)/cost-utility analyses (CUAs) that were entirely based on medico-administrative databases. The review reported the main choices of economic evaluation methods in the analyses. The quality of the articles was assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) and risk of bias assessment checklists.ResultsOf the 306 records identified in PubMed, 12 articles were selected, and one additional article was identified through Web of Science. Ten of the 13 articles were CEAs and three were CUAs. Most of the analyses were carried out in North America (n\u2009=\u200911). The economic metric used was the cost per life-year gained (n\u2009=\u200910) or cost per quality-adjusted life-year (n\u2009=\u20093). Reporting of the target analysis population and strategies in the articles was in agreement with the CHEERS guidelines. The structural assumptions underpinning the economic models displayed the poorest reporting quality among the items analysed. Representativeness bias (n\u2009=\u200911) and the issue of censored medical costs (n\u2009=\u20098) were the most frequently analysed risks.ConclusionA comparison of the economic results was not relevant due to the high heterogeneity of the selected studies. Our SLR highlighted the benefits and pitfalls related to the use of medico-administrative databases in the economic evaluations of anticancer drugs.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40258-020-00562-z", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1031175", 
        "issn": [
          "1175-5652", 
          "1179-1896"
        ], 
        "name": "Applied Health Economics and Health Policy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "18"
      }
    ], 
    "keywords": [
      "Consolidated Health Economic Evaluation Reporting Standards", 
      "cost-effectiveness analysis", 
      "economic evaluation", 
      "economic evaluation methods", 
      "new drug development projects", 
      "economic model", 
      "medico-administrative database", 
      "economic results", 
      "CHEERS guidelines", 
      "economic metrics", 
      "poor reporting quality", 
      "utility analysis", 
      "representativeness bias", 
      "reporting standards", 
      "reporting quality", 
      "drug development projects", 
      "expensive drugs", 
      "structural assumptions", 
      "cost effectiveness", 
      "medical costs", 
      "anticancer drugs", 
      "main choice", 
      "systematic literature review", 
      "cost", 
      "Web of Science", 
      "clinical benefit", 
      "analysis population", 
      "development projects", 
      "real-world data", 
      "clinical practice", 
      "benefits", 
      "additional articles", 
      "literature review", 
      "article", 
      "assessment checklist", 
      "drugs", 
      "choice", 
      "PubMed", 
      "therapeutic field", 
      "evaluation method", 
      "high heterogeneity", 
      "heterogeneity", 
      "risk", 
      "assumption", 
      "review", 
      "search strategy", 
      "strategies", 
      "analysis", 
      "ResultsOf", 
      "database", 
      "evaluation", 
      "bias", 
      "America", 
      "issues", 
      "MethodsWe", 
      "quality", 
      "model", 
      "treatment", 
      "input", 
      "objective", 
      "terms", 
      "guidelines", 
      "checklist", 
      "standards", 
      "North America", 
      "data", 
      "population", 
      "project", 
      "values", 
      "items", 
      "records", 
      "CuA", 
      "study", 
      "science articles", 
      "pitfalls", 
      "effectiveness", 
      "results", 
      "Web", 
      "science", 
      "use", 
      "practice", 
      "metrics", 
      "agreement", 
      "comparison", 
      "such databases", 
      "method", 
      "field"
    ], 
    "name": "Economic Evaluations of Anticancer Drugs Based on Medico-Administrative Databases: A Systematic Literature Review", 
    "pagination": "491-508", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1124867534"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40258-020-00562-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "32056121"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40258-020-00562-z", 
      "https://app.dimensions.ai/details/publication/pub.1124867534"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:37", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_857.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40258-020-00562-z"
  }
]

Download the RDF metadata as:  json-ld nt turtle xml License info

This table displays all metadata directly associated to this object as RDF triples.

249 TRIPLES      22 PREDICATES      133 URIs      113 LITERALS      16 BLANK NODES